Arq Past Earnings Performance
Past criteria checks 0/6
Arq has been growing earnings at an average annual rate of 71.1%, while the Chemicals industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 28.7% per year.
Key information
71.1%
Earnings growth rate
80.7%
EPS growth rate
Chemicals Industry Growth | 12.9% |
Revenue growth rate | 28.7% |
Return on equity | -2.4% |
Net Margin | -4.7% |
Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
Recent updates
Slammed 29% Arq, Inc. (NASDAQ:ARQ) Screens Well Here But There Might Be A Catch
Apr 09Does Arq (NASDAQ:ARQ) Have A Healthy Balance Sheet?
Mar 28Arq: Granular Activated Carbon Expansion Project Remains A Headache - Hold
Mar 07Arq, Inc.'s (NASDAQ:ARQ) 30% Jump Shows Its Popularity With Investors
Nov 22Arq: Surprise Equity Offering Raises Questions (Rating Downgrade)
Sep 20Whether Or Not Trump Wins In November, Arq Is A $10 Stock
Aug 204 Reasons To Buy Arq Stock
May 30Does Arq (NASDAQ:ARQ) Have A Healthy Balance Sheet?
Apr 11Arq, Inc.: A Pot Of Gold At The End Of The Rainbow
Mar 18Revenue & Expenses Breakdown
How Arq makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 24 | 109 | -5 | 32 | 4 |
30 Sep 24 | 110 | 0 | 36 | 1 |
30 Jun 24 | 105 | -4 | 39 | 1 |
31 Mar 24 | 100 | -8 | 40 | 1 |
31 Dec 23 | 99 | -12 | 36 | 3 |
30 Sep 23 | 94 | -19 | 38 | 2 |
30 Jun 23 | 93 | -19 | 34 | 2 |
31 Mar 23 | 97 | -14 | 32 | 1 |
31 Dec 22 | 103 | -9 | 32 | 0 |
30 Sep 22 | 80 | -102 | 26 | 1 |
31 Dec 21 | 0 | -116 | 16 | 4 |
Quality Earnings: ARQ is currently unprofitable.
Growing Profit Margin: ARQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARQ is unprofitable, but has reduced losses over the past 5 years at a rate of 71.1% per year.
Accelerating Growth: Unable to compare ARQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ARQ is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (2.4%).
Return on Equity
High ROE: ARQ has a negative Return on Equity (-2.35%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/04/19 04:23 |
End of Day Share Price | 2025/04/17 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arq, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
George Gianarikas | Canaccord Genuity |
Gerard Sweeney | Roth Capital Partners |
Graham Mattison | Water Tower Research LLC |